Definitive Contract 75N91020C00014
Award Date
9/16/20
Potential Completion Date
7/31/21
Potential Value
$400K
Federal Agency
National Cancer Institute
Awardee
Apricity Health LLC
Ultimate Awardee
Not listed
NAICS Category
541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Federal Contract Vehicle
Set-Aside Type
Total Small Business
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Houston, TX 77019, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
14
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This $399,987 Small Business Innovation Research (SBIR) Phase I contract was awarded by the National Cancer Institute (NCI), a part of the National Institutes of Health (NIH), to Care Progress LLC, a small business limited liability company. The contract supports the development of cancer clinical trials recruitment and retention tools for participant engagement, as described in the original SBIR solicitation. The solicitation sought proposals for SBIR Phase I and Phase II contracts to conduct...
This is a $399,992 firm fixed price SBIR Phase I contract awarded by the National Cancer Institute (NCI) to Xanthoshealth, Inc., a small business concern, to develop "Software to Address Social Determinants of Health in Oncology Practices" under the NCI's SBIR program. The original solicitation sought proposals for innovative research across various biomedical and public health topics, including digital health tools, to contribute towards the NCI and Centers for Disease Control and...
This $400,000 firm fixed price contract was awarded by the National Institutes of Health National Cancer Institute to Melax Technologies Inc., doing business as Private, for SBIR Phase I research titled "Cancer Clinical Trials Recruitment and Retention Tools for Participant Engagement." The solicitation sought proposals to support NIH and CDC agency missions through research topics including cancer imaging tools, clinical trials tools, and cancer informatics software. The University of...
This is a Firm Fixed Price contract awarded by the National Cancer Institute (NCI), a civilian federal agency, to Pieces Technologies Inc., a small business, under the Small Business Innovation Research (SBIR) Phase II program. The contract, worth $1,999,994.00, is for the project titled "Passive and Active AI Screening for Social Determinants of Health and Interventions to Improve Outcomes in the Cancer Patient Population." The contract has a period of performance from September 16,...
This definitive contract was awarded by the National Institutes of Health National Cancer Institute to Massive Bio, Inc. for $399,594. The contract is associated with the National Institutes of Health and Centers for Disease Control and Prevention SBIR Phase I solicitation seeking proposals for research and development in support of cancer-related topics including clinical trials recruitment and retention tools for participant engagement. The contract will be performed in New York, New York from...
This is a $355,000.00 Firm Fixed Price definitive contract awarded by the National Cancer Institute (NCI), a civilian agency within the U.S. Department of Health and Human Services, to Immunotarget Therapeutics Inc., a woman-owned small business. The contract is for the NCI's Small Business Innovation Research (SBIR) Innovative Concept Award program, which seeks proposals for highly innovative therapies, diagnostic tools, or preventive strategies focused on pediatric and/or rare cancers. The...
This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Cancer Institute (NCI), an institute of the National Institutes of Health (NIH), to Lucidact Inc., a minority-owned and disadvantaged small business located in Los Angeles, CA. The $454,524 fixed-price contract is for the development of a digital tool to integrate cancer prevention within primary care, as part of the broader SBIR program objectives to stimulate technological innovation and strengthen the...
This $390,181 firm fixed price contract was awarded by the National Institutes of Health National Cancer Institute to Smart Information Flow Technologies LLC for research activities aligned with TOPIC 425: CHARACTERIZING HUMAN ACTIVITIES FOR CANCER HEALTH AWARENESS under the Small Business Innovation Research Program Phase I solicitation. The prime contractor will conduct research and development at its Minneapolis, Minnesota location to deliver innovative solutions in cancer health awareness as...
This is a $289,828.00 SBIR Phase I contract awarded by the Department of Health and Human Services' National Institutes of Health National Cancer Institute to Nicolalde R&D LLC, a minority-owned, self-certified small disadvantaged business. The contract is a firm fixed-price definitive contract with a completion date of November 30, 2021. The SBIR (Small Business Innovation Research) Program Phase I award indicates this contract is for early-stage research and development activities. As a...
This SBIR Phase I contract from the National Cancer Institute, valued at $361,254, was awarded to Avident Health LLC. The firm will develop its MyNavigator mHealth application for use in patient navigator breast cancer care workflows, as requested under NIH Solicitation 406. This total small business set-aside solicitation sought proposals for Phase I and Phase II SBIR contracts to conduct R&D supporting NIH and CDC agency missions, including alternatives to cell culture materials and cancer...